I want to ask you about a specific provision of the discussion draft that allows the FDA to include requirements for the...
I really want to thank you for going through regular order with this bill, because I think that this is one of those iss...
Thank you very much, and thank you for all of your efforts and your agency's efforts.
What this would do is give the FDA new tools to protect consumers.
I would like to thank you for working on this important bill with us.
It has been 40 years that we have had this monograph system, but we haven't really made any updates to it.
The 17 labs of the DOE are national assets that have contributed profoundly to the nation's security, scientific leaders...
I enjoy the opportunity, always, to work with the Ranking Member, Senator Manchin, to address these key topics in Energy...
Is it your understanding that the 1332 Waiver, as is it written now, would allow a State, if it wanted to, to apply to h...
I would also share the view, as a couple of you suggested that one source of great unhappiness that I hear about from pe...
I believe our national labs are catalysts that have accelerated or made possible many innovations.
How we choose to invest in our national labs and support the scientists within them is critical going forward.
We need immediate Federal action and responsible reforms that preserve coverage gains and control costs.
I am grateful to my legislative colleagues on both sides of the aisle for being willing to put politics aside to improve...
We need to move toward a system that compensates quality and good health, not quantity.
It's time for the Federal Government to work with us, not against us.
And to add to that, let me say words that have not been said in the Senate before. My questions have been asked.
We urge you in the strongest terms to renew funding for this important program through 2022 at the currently established...
